Aethlon Medical (AEMD) Change in Accured Expenses (2010 - 2026)
Aethlon Medical's (AEMD) quarterly Change in Accured Expenses came in at $362450.0 in Q1 2026, up 45.72% YoY from $248736.0 in Q1 2025, and up 186.7% quarter-over-quarter from -$418055.0 in Q4 2025.
Aethlon Medical (AEMD) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Aethlon Medical's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at $362450.0 for Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 45.72% year-over-year to $362450.0; the trailing twelve-month figure through Mar 2026 stood at -$383384.0 (down 618.49% YoY), and the FY2026 full-year result was -$383384.0, down 618.49% from the prior year.
- Change in Accured Expenses was $362450.0 for Q1 2026 at Aethlon Medical, up from -$418055.0 in the prior quarter.
- Over the last five years, Change in Accured Expenses for AEMD reached as high as $540780.0 in Q1 2022 and fell as low as -$418055.0 in Q4 2025.
- Median Change in Accured Expenses over the past 5 years was -$25892.0 (2023), compared with a mean of $5058.1.
- Across the five-year window, Change in Accured Expenses tumbled 1435.09% in 2024 and soared 1118.7% in 2025, its largest moves.
- Over 5 years, Change in Accured Expenses stood at $304572.0 in 2022, then tumbled by 108.5% to -$25892.0 in 2023, then tumbled by 1435.09% to -$397466.0 in 2024, then declined by 5.18% to -$418055.0 in 2025, then surged by 186.7% to $362450.0 in 2026.
- Business Quant data shows AEMD's Change in Accured Expenses at $362450.0 in Q1 2026, -$418055.0 in Q4 2025, and -$190287.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Aethlon Medical | 3.70 Mn | -1.32 Mn | - | 362,450.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 362,450.00 |
| Mar 31, 2026 | 362,450.00 |
| Dec 31, 2025 | -418,055.00 |
| Dec 31, 2025 | -418,055.00 |
| Sep 30, 2025 | -190,287.00 |
| Sep 30, 2025 | -190,287.00 |
| Jun 30, 2025 | -137,492.00 |
| Jun 30, 2025 | -137,492.00 |
| Mar 31, 2025 | 248,736.00 |
| Mar 31, 2025 | 248,736.00 |
| Dec 31, 2024 | -397,466.00 |
| Dec 31, 2024 | -397,466.00 |
| Sep 30, 2024 | -228,406.00 |
| Sep 30, 2024 | -228,406.00 |
| Jun 30, 2024 | 323,776.00 |
| Jun 30, 2024 | 323,776.00 |
| Mar 31, 2024 | 20,410.00 |
| Mar 31, 2024 | 20,410.00 |
| Dec 31, 2023 | -25,892.00 |
| Dec 31, 2023 | -25,892.00 |